US Patent 9828384 Spiro-lactam NMDA receptor modulators and uses thereof
Patent 9828384 was granted and assigned to Aptinyx Inc. on November, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9828384 Spiro-lactam NMDA receptor modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
